Sugi Predict

Sugi Predict / Compounds / SCHEMBL3410573

SCHEMBL3410573

SCHEMBL3410573

CCCCCCCC/C=C\CCCCCCCCCCCC(=O)O[C@@H](CO)COP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.76
▸ SMN1; SMN2 Q16637 1/20 0.73
▸ NR5A2 O00482 1/20 0.73
▸ NR5A1 Q13285 1/20 0.73
▸ RECQL P46063 1/20 0.68
▸ MAPT P10636 1/20 0.64
▸ S1PR1 P21453 2/20 0.63
▸ PRKCA P17252 2/20 0.59
▸ PRKCE Q02156 1/20 0.59
▸ PRKCQ Q04759 1/20 0.59
▸ PRKCD Q05655 1/20 0.59
▸ DAGLA Q9Y4D2 1/20 0.58
▸ ADRA1D P25100 1/20 0.58
▸ PTAFR P25105 1/20 0.58
▸ HTR1D P28221 1/20 0.58
▸ HTR2C P28335 1/20 0.58
▸ ADRA1B P35368 1/20 0.58
▸ DRD3 P35462 1/20 0.58
▸ TMEM97 Q5BJF2 1/20 0.58
▸ MEN1 O00255 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29410678 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL30652061 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL3406499 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL3403745 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL3406019 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL3407855 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL753300 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL3405833 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL5053766 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL30521870 1.00 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12226740-B2 Stabilized filtration device RETEIN AB (SE) 2025-02-18 — — US claimed
US-20220152559-A1 STABILIZED FILTRATION DEVICE RETEIN AB (SE) 2022-05-19 — — US claimed
EP-3930884-A1 STABILIZED FILTRATION DEVICE Aquammodate AB (SE) 2022-01-05 — — EP claimed
US-20080160313-A1 Lipid bilayers on nanotextured solid surfaces ENERGY, U.S. DEPARTMENT OF 2008-07-03 — — US claimed
US-20020102297-A1 Macromolecule-lipid complexes and methods for making and using THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-08-01 — — US claimed
WO-2000000033-A1 MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-01-06 — — WO claimed
US-12226740-B2 Stabilized filtration device RETEIN AB (SE) 2025-02-18 — — US disclosed
US-20220152559-A1 STABILIZED FILTRATION DEVICE RETEIN AB (SE) 2022-05-19 — — US disclosed
EP-3930884-A1 STABILIZED FILTRATION DEVICE Aquammodate AB (SE) 2022-01-05 — — EP disclosed
EP-3120872-B1 DUAL-PURPOSE PAT/ULTRASOUND CONTRAST AGENT BOUND WITH NANOPARTICLES CONTAINING DRUG AND METHOD FOR PREPARING SAME IMGT CO LTD (KR) 2021-06-09 — — EP disclosed
US-10912848-B2 Dual-purpose PAT/ultrasound contrast agent bound with nanoparticles containing drug and method for preparing same IMGT CO, LTD. (KR) 2021-02-09 — — US disclosed
US-9943812-B2 Artificial membrane-fixed liquid filtration structure INHA-INDUSTRY PARTNERSHIP INSTITUTE (KR) 2018-04-17 — — US disclosed
US-20170080114-A1 Dual-Purpose Pat/Ultrasound Contrast Agent Bound with Nanoparticles Containing Drug and Method for Preparing Same IMGT CO, LTD. (KR) 2017-03-23 — — US disclosed
US-6207186-B1 CALIBRATION, CONTROLLING STRUCTURE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-03-27 — — US disclosed
WO-2000000033-A1 MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-01-06 — — WO disclosed
EP-0958380-A1 MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING The Regents of The University of California (US) 1999-11-24 — — EP disclosed
WO-1998035828-A9 LAMELLAR GELS AND METHODS FOR MAKING AND REGULATING — 1999-02-04 — — WO disclosed
WO-1998024936-A9 MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING — 1998-10-01 — — WO disclosed
WO-1998035828-A1 LAMELLAR GELS AND METHODS FOR MAKING AND REGULATING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-08-20 — — WO disclosed
WO-1998024936-A1 MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10912848-B2 Dual-purpose PAT/ultrasound contrast agent bound with nanoparticles containing drug and method for preparing same DUOX2, PLAT, NPPA ALDH1A1 4153/4885SMN1; SMN2 4857/4885NR5A2 2032/4885
US-20170080114-A1 Dual-Purpose Pat/Ultrasound Contrast Agent Bound with Nanoparticles Containing Drug and Method for Preparing Same DUOX2, PLAT, NPPA ALDH1A1 4153/4885SMN1; SMN2 4857/4885NR5A2 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.